A Case of Anti-TNFα Therapies Induced Lupus Panniculitis Successfully Improved With a JAK Inhibitor (Baricitinib)

被引：0
|
作者：
Grechin, Cristina [1 ]
Doheny, Jane [2 ]
Pilson, Keith [2 ]
Howard, Donough [3 ]
Roche, Muireann [1 ]
机构：
[1] Beaumont Hosp, Dermatol Dept, Dublin, Ireland
[2] Beaumont Hosp, Histopathol Dept, Dublin, Ireland
[3] Beaumont Hosp, Rheumatol Dept, Dublin, Ireland
来源：
JEADV CLINICAL PRACTICE | 2025年
关键词：
anti-TNF-alpha therapies; JAK inhibitor; lupus panniculitis; rheumatoid arthritis; ADALIMUMAB;
D O I：
10.1002/jvc2.626
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%-3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti-TNF-alpha therapies. Clinically, it is characterised by tender, erythematous subcutaneous indurated nodules or plaques on fatty body areas. It can occur frequently alone or in combination with systemic erythematous lupus or discoid lupus. The pathogenic mechanism of anti-TNF-alpha therapies induced lupus panniculitis is not well understood. Our case report and literature review highlight that anti-TNF-alpha therapies can induce lupus panniculitis, especially in the rheumatoid arthritis cohort of patients.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] SAFETY AND EFFICACY OF ABT-494, A NOVEL SELECTIVE JAK1 INHIBITOR, IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO ANTI-TNF BIOLOGIC THERAPY
    Kremer, J. M.
    Keystone, E. C.
    Emery, P.
    Camp, H. S.
    Friedman, A.
    Wang, L.
    Othman, A. A.
    Khan, N.
    Jungerwirth, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1038 - 1039
  • [42] Case series: A review of 8 patients with drug-associated systemic lupus erythematosus and positive dsDNA after commencing anti-TNF biologic agents
    Cox, V.
    Marshman, G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 34 - 34
  • [43] A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?
    Tânia Santiago
    Mariana Galante Santiago
    João Rovisco
    Cátia Duarte
    Armando Malcata
    José António Pereira da Silva
    Clinical Rheumatology, 2013, 32 : 1819 - 1822
  • [44] A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?
    Santiago, Tania
    Santiago, Mariana Galante
    Rovisco, Joao
    Duarte, Catia
    Malcata, Armando
    Pereira da Silva, Jose Antonio
    CLINICAL RHEUMATOLOGY, 2013, 32 (12) : 1819 - 1822
  • [45] Efficacy of filgotinib, a selective JAK1 inhibitor, is independent of prior anti-TNF exposure: subgroup analysis of the phase 2 FITZROY study in moderate-to-severe Crohn's disease
    D'Haens, G.
    Schreiber, S.
    Petryka, R.
    Kuehbacher, T.
    Hebuterne, X.
    Roblin, X.
    Klopocka, M.
    Goldis, A.
    Wisniewska-Jarosinska, M.
    Baranovsky, A.
    Sike, R.
    Stoyanova, K.
    Meuleners, L.
    Tasset, C.
    Van der Aa, A.
    Harrison, P.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S70 - S71
  • [46] EFFICACY OF FILGOTINIB, A SELECTIVE JAK1 INHIBITOR, IS INDEPENDENT OF PRIOR ANTI-TNF EXPOSURE: SUBGROUP ANALYSIS OF THE PHASE 2 FITZROY STUDY IN MODERATE-TO-SEVERE CROHN'S DISEASE
    D'Haens, Geert R.
    Schreiber, Stefan
    Petryka, Robert
    Kuehbacher, Tanja
    Hebuterne, Xavier
    Roblin, Xavier
    Klopocka, Maria
    Goldis, Adrian
    Wisniewska-Jarosinska, Maria A.
    Baranovsky, Andrei
    Sike, Robert
    Stoyanova, Kremena
    Meuleners, Luc
    Tasset, Chantal T.
    Van der Aa, Annegret
    Harrison, Pille
    Vermeire, Severine
    GASTROENTEROLOGY, 2017, 152 (05) : S597 - S597
  • [47] A Patient With Ulcerative Colitis on Long Term Anti-TNF Alpha Therapies Presents With Weight Loss and Anemia: A Case Report of Diffuse Large B-cell Lymphoma
    Wuthnow, Chelsea
    Johnson, Luke
    Gorantla, Saritha
    Tofteland, Nathan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1481 - S1482
  • [48] COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy
    Liu, Z.
    Alexander, J.
    Le, K.
    Zhou, X.
    Ibraheim, H.
    Anandabaskaran, S.
    Saifuddin, A.
    Lin, K.
    Mcfarlane, L.
    Anand, N.
    Constable, L.
    Castro-Seoane, R.
    Nice, R.
    Bewshea, C.
    D'Mello, A.
    Jones, G. R.
    Balarajah, S.
    Fiorentino, F.
    Sebastian, S.
    Irving, P.
    Hicks, L.
    Williams, H.
    Kent, A.
    Linger, R.
    Parkes, M.
    Kok, K.
    Patel, K. V.
    Teare, J.
    Altmann, D.
    Hart, A.
    Lees, C.
    Boyton, R.
    Goodhand, J.
    Kennedy, N.
    Pollock, K.
    Ahmad, T.
    Powell, N.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 664 - 664
  • [49] Anti-TNF-monoclonal antibodies/Disease modifying antirheumaticsDrug-induced lupus erythematosus and lack of efficacy: 2 case reports
    Reactions Weekly, 2021, 1864 (1) : 34 - 34
  • [50] Anti-TNF-α-induced lupus syndrome: Two case reports and review of current literature; [Anti-TNF-α-induziertes Lupussyndrom: Übersicht über die aktuelle Literatur und 2 Kasuistiken]
    Sieiro Santos C.
    Álvarez Castro C.
    Moriano Morales C.
    Díez Álvarez E.
    Zeitschrift für Rheumatologie, 2021, 80 (5) : 481 - 486
12345